Related Experiment Video
Updated: Jun 7, 2026
07:32
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
A novel adjuvant for vaccine development in the aged
Edward L Morgan1, Marilyn L Thoman, Sam D Sanderson
1San Diego State University, Biosciences Center, 5500 Campanile Drive, San Diego, CA 92182, USA. emorgan@sciences.sdsu.edu
Vaccine
|October 23, 2010
Summary
EP67, a novel agonist, effectively stimulates immune responses in aged mice. This vaccine adjuvant enhances antibody production, offering a promising solution for elderly immunity.
Area of Science:
- Immunology
- Vaccinology
- Gerontology
Background:
- Aging is associated with diminished immune function, impacting vaccine efficacy.
- Current vaccine adjuvants like alum and CpG have limitations in stimulating robust immune responses in the elderly.
- EP67 is a conformationally-biased, response-selective agonist of human C5a(65-74).
Purpose of the Study:
- To evaluate the potential of EP67 as a vaccine adjuvant in aged mice.
- To compare the immunogenicity of EP67-containing vaccines with traditional adjuvants.
Main Methods:
- EP67 activated antigen-presenting cells (APCs) in vitro.
- Mice were immunized with ovalbumin (OVA-EP67) or Coccidioides protein (rPrp1-EP67) vaccines.
- Humoral immune responses, including antigen-specific antibody titers (IgG, IgG1, IgG2b), were measured.
Main Results:
- EP67 induced pro-inflammatory cytokines (IL-6, TNFα, INFγ) from splenic APCs.
- EP67-containing vaccines generated high antigen-specific IgG titers in both young and aged mice.
- EP67 vaccines elicited higher IgG titers (IgG1 and IgG2b) compared to OVA/alum and rPrp1 +CpG adjuvants.
Conclusions:
- EP67 effectively induces humoral immunity in aged mice.
- EP67 demonstrates superior adjuvant activity compared to alum and CpG in aged populations.
- EP67 shows promise as a vaccine adjuvant for enhancing immunity in the elderly.
Related Concept Videos
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...